News
10-07-2014, 08:00 PM
NanoString Technologies, Inc., a provider of life science tools for translational research and molecular diagnostic products, today announced that it has signed a multi-year, multi-investigator research collaboration with Harvard-affiliated Brigham and Women's Hospital to accelerate the translation of genomic biomarker discoveries into clinical cancer diagnostics.
More... (http://www.news-medical.net/news/20141007/NanoString-BWH-partner-to-translate-genomic-biomarker-discoveries-into-clinical-cancer-diagnostics.aspx)
More... (http://www.news-medical.net/news/20141007/NanoString-BWH-partner-to-translate-genomic-biomarker-discoveries-into-clinical-cancer-diagnostics.aspx)